News

AddToAny

Google+ Facebook Twitter Twitter

The contribution of viral pathogens to sepsis

SARS-CoV-2 accounted for one in six cases of sepsis during the first 33 months of the COVID-19 pandemic, highlighting the importance of viral sepsis, according to a new study.

Although sepsis is usually equated with bacterial infection, the pandemic has made it clear that viral infections can be an important cause of sepsis.

Few studies, however, have quantified the contribution of viral infections to the overall burden of sepsis and how the outcomes of patients with viral sepsis compare to those with bacterial sepsis.

The study researchers performed a retrospective cohort study using electronic health record (HER) data for all adults admitted to five Massachusetts hospitals from March 2020 to November 2022.

The team quantified the incidence and in-hospital mortality for sepsis associated with SARS-CoV-2 infections using clinical criteria adapted from Centers for Disease Control and Prevention.

They found that approximately one in six cases of sepsis were associated with SARS-CoV-2 during this period. The mortality rate for patients with SARS-CoV-2-associated sepsis was very high initially—33% over the first three months of the pandemic—but declined over time and eventually became similar to the mortality rate for presumed bacterial sepsis, a rate of about 14.5% that remained stable throughout the study period.

bit.ly/3PYO023

Image credit | Science-Photolibrary

Related Articles

Flying geese at evening in New York City - CREDIT - Getty-1424137210

Avian flu detected in New York City wild birds

A small number of New York City wild birds carry the highly pathogenic H5N1 avian influenza, according to a recent study published in the Journal of Virology.

The rise of antibiotic-resistant bacterial infections . CREDIT- istock-1495083577

Novel triple antibiotic combo

A novel triple antibiotic combination offers a potential breakthrough in combatting antibiotic resistance, it is claimed.

Doctor's hands vaccinating a woman stock photo CREDIT-iStock-1444188743

A universal vaccine?

Scientists have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies and the immunocompromised.

Top